Independent pharmacy owners make dozens, sometimes hundreds, of financial decisions every day.
Every prescription represents a balance between serving patients and maintaining a healthy business. The challenge is that reimbursement is becoming increasingly complex, making it harder to know what a prescription will actually contribute to your bottom line.
One of the latest examples is Medicare’s Maximum Fair Price (MFP) program.
As more drugs become subject to MFP pricing, pharmacies need better visibility into how these claims impact expected margins. Waiting until after adjudication or reconciliation can create uncertainty and make it difficult to evaluate profitability in real time.
That’s why RxBLU has introduced a new enhancement designed to help pharmacies see a more accurate picture of their expected margin during claim processing.
What Is MFP?
The Medicare Drug Price Negotiation Program established under the Inflation Reduction Act allows Medicare to negotiate prices for certain high cost medications.
The resulting negotiated amount is referred to as the Maximum Fair Price, or MFP.
As MFP eligible medications become more common, pharmacies need to understand how these pricing adjustments affect reimbursement and profitability.
The challenge is that these changes can be difficult to detect within the normal prescription-processing workflow.
The Visibility Problem
Many pharmacies focus on reimbursement, acquisition costs, and expected margins when evaluating prescriptions.
But when MFP is involved, the expected margin may not always be immediately obvious.
Without clear visibility, pharmacy teams may find themselves asking:
- Is this claim subject to MFP pricing?
- Has the MFP value been applied?
- What does this mean for my expected margin?
- Am I seeing the most accurate financial picture before dispensing?
The more uncertainty that exists, the harder it becomes to make informed business decisions.
How RxBLU Helps
RxBLU has enhanced claim processing by adding BLU-AI to help identify claims with MFP pricing.
When BLU-AI detects MFP within a claim, RxBLU automatically:
- Identifies the MFP opportunity during claim processing
- Displays the MFP value for visibility
- Highlights the letters MFP in yellow for easy recognition
- Incorporates the value into expected margin calculations
- Allows users to adjust the value back to zero when necessary
This gives pharmacy teams immediate awareness of how MFP may affect the prescription before they move forward.
A More Accurate Expected Margin
The goal is simple: provide a more accurate expected margin calculation during prescription processing.
When pharmacies have better information, they can make better decisions.
Instead of searching through claim details or trying to determine whether MFP pricing applies, the information is surfaced directly within the workflow.
That means:
- Greater visibility
- Faster identification of MFP opportunities
- Improved confidence in expected margin calculations
- Less guesswork during claim review
For pharmacy owners, that translates into a clearer understanding of prescription profitability.
Technology Should Help You See More
At RxBLU, we believe pharmacy software should do more than process prescriptions.
It should help pharmacies identify opportunities, reduce uncertainty, and make informed decisions.
The addition of BLU-AI powered MFP identification is another example of how RxBLU is helping community pharmacies stay ahead of industry changes while maintaining visibility into the numbers that matter most.
Because when margins matter, better information matters too.
See RxBLU in Action
Want to learn more about how RxBLU is helping pharmacies gain greater visibility into profitability, reimbursement, and workflow efficiency?
Book a quick call and see how RxBLU is building tools designed for the modern community pharmacy.
Schedule a demo:
.avif)
